- Bookmark
- Share
- CaseIQ
Resolution Chemicals Ltd v H Lundbeck A/S
Factual and Procedural Background
The case concerns European Patent (UK) No. 0 347 066 ("the Patent") and its associated supplementary protection certificate ("the SPC"), both relating to escitalopram, a drug used for treating depression. The Patent proprietor is Company A, a Danish pharmaceutical company. The UK Patent was previously challenged in revocation proceedings commenced in 2005 by Company B and other generic pharmaceutical companies, including Company C, which was part of the same group as the claimant in the current action ("Plaintiff") at that time.
In the present action, Plaintiff, now an independent company, launched its own challenge against the SPC based on the invalidity of the Patent, relying on evidence it claims is superior and introducing new prior art. Company A contends that Plaintiff is precluded from bringing this action due to privity of interest with Company C, which is estopped from raising similar claims due to the earlier 2005 proceedings. A preliminary issue on this question was tried by Judge A, who ruled that Plaintiff was not precluded from challenging the Patent or SPC. Company A appeals with permission.
Prior to this appeal, Company A sought summary judgment on the basis that Plaintiff's claim had no prospect of success; this was dismissed by Judge A and is not appealed. Company A also no longer pursues a claim that Plaintiff was precluded due to privity with other companies in a related group.
Judge A found it common ground that Company C would be estopped from challenging the SPC’s validity on grounds that the Patent is invalid, either by issue estoppel or abuse of process, though the precise basis was debated.
The judge made extensive factual findings regarding Plaintiff's and Company C's relationship within the same corporate group from 2001 to 2009, including the control exerted by a key individual, the business activities related to escitalopram and citalopram, and the corporate structure changes leading to Plaintiff's independence in 2009. It was found that Plaintiff had no concrete interest in escitalopram by 2006 and had ceased relevant development activities by 2004.
The 2005 proceedings concluded with the House of Lords dismissing the claims, and Plaintiff was not a party to those proceedings. Plaintiff had no involvement in those proceedings or in supplying escitalopram at the relevant time.
Legal Issues Presented
- Whether Plaintiff is precluded from challenging the validity of the Patent and SPC by reason of privity of interest with Company C, which is estopped by the judgment in the 2005 proceedings.
- Whether the judge erred in law or principle in concluding that Plaintiff was not bound by the earlier judgment despite the corporate relationship with Company C.
- Whether a broad, merits-based approach to abuse of process estoppel would lead to a different conclusion regarding Plaintiff’s ability to bring the present action.
Arguments of the Parties
Company A's Arguments
- Plaintiff is in privity of interest with Company C because both were part of the same corporate group controlled by a common individual who managed patent litigation for the group.
- Plaintiff had knowledge of the earlier proceedings and chose to stand back, allowing Company C to conduct the litigation on its behalf, thus should be estopped from relitigating.
- Plaintiff had a direct legal interest in the outcome of the 2005 proceedings, including its "freedom to operate" regarding escitalopram, supported by prior development efforts and investigations into manufacturing routes.
- The judge erred in principle by failing to recognize that allowing Plaintiff to litigate anew would violate the principle that no person should be vexed twice in the same cause and would undermine estoppel principles within corporate groups.
Plaintiff's Arguments
- Plaintiff was an independent entity by the time of the current proceedings and had no concrete or continuing interest in escitalopram at the time of the 2005 proceedings.
- There was no subsisting relationship that would make the earlier litigation conducted on Plaintiff’s behalf; Company C was the proper party with an interest in the 2005 proceedings.
- Prior efforts by Plaintiff to develop escitalopram had ceased by 2004 and it was not capable of supplying escitalopram at the time; therefore, Plaintiff lacked a sufficient interest to be bound by the earlier judgment.
- The principle of fairness and procedural protections require that a party be joined to proceedings to be bound by a judgment; Plaintiff was not a party and did not stand by to let Company C fight its battle.
- Applying a broad merits-based approach to abuse of process estoppel supports Plaintiff’s entitlement to bring the current action, especially given its independence and changed business model.
Table of Precedents Cited
| Precedent | Rule or Principle Cited For | Application by the Court |
|---|---|---|
| Gleeson v J Wippell & Co [1977] 1 WLR 510 | Definition and scope of privity of interest in estoppel; narrow doctrine requiring sufficient degree of identification. | Applied to assess whether Plaintiff’s relationship with Company C was sufficient to bind Plaintiff to the earlier judgment; court found insufficient privity. |
| Johnson v Gore Wood [2002] 2 AC 1 | Endorsement of Gleeson principles; broad merits-based approach to abuse of process estoppel; balancing fairness and finality. | Guided court’s consideration of whether estoppel should apply to Plaintiff; supported the conclusion that Plaintiff was not estopped. |
| House of Spring Gardens Ltd v Waite [1991] QB 241 | Privity by conduct where party knowingly stands by and lets another litigate on their behalf. | Considered and rejected on facts as Plaintiff did not stand by or participate in the earlier litigation. |
| Wytcherley v Andrews (1871) LR 2 P&M 327 | Class or representative actions and binding effect of judgments on privies who stand by. | Referenced in assessing whether Plaintiff was a privy bound by the 2005 proceedings; court found no such binding relationship. |
| Nana Ofori Atta II v Nanu Aba Bonsra II [1958] AC 58 | Support for principle of representative actions and privity binding effect. | Used to explain narrowness of exceptions to general rule that only parties to litigation are bound. |
| Seven Arts Entertainment Ltd v Content Media Corp plc [2013] EWHC 588 (Ch) | Fairness requires a party to be joined to proceedings before being bound by judgment; narrow exceptions to this rule. | Supported court’s emphasis on procedural fairness in determining estoppel and privity. |
| Aldi Stores Limited v WSP Group plc [2007] EWCA Civ 1 | Broad merits-based approach to abuse of process estoppel; rejection of formulaic application of privity. | Considered but not relied on by parties; court noted it would not alter outcome. |
| Special Effects Ltd v L'Oréal SA [2007] EWCA Civ 1 | Privity of interest within corporate groups and application of estoppel principles. | Discussed by court to distinguish from present case; court found facts here materially different. |
| Zeiss No 2 [1967] 1 AC 853 | Identification of parties and estoppel of agents or servants acting on behalf of a principal. | Referenced to illustrate when estoppel applies to related parties; court found no such identity here. |
Court's Reasoning and Analysis
The court began by recognizing the competing principles: the protection against being vexed twice in the same cause and the right of an independent party to bring a fresh claim. The doctrine of privity of interest, a narrow exception to the general rule that estoppel binds only parties to earlier proceedings, requires a sufficient degree of identification between the new party and the earlier party.
The judge’s detailed factual findings showed that Plaintiff and Company C, although once part of the same corporate group, had distinct business models and interests by 2006. Plaintiff had ceased active involvement in escitalopram development by 2004 and was unable to manufacture the product. Company C was the party with a concrete interest in the 2005 proceedings. Plaintiff’s interest was speculative and insufficient to justify binding it by the earlier judgment.
The court rejected Company A’s argument that Plaintiff stood by and allowed Company C to litigate on its behalf, finding no evidence of such conduct. The court also declined to adopt a rigid test that would bar Plaintiff simply because it had been part of the same group, emphasizing fairness and procedural protections.
Considering a broad, merits-based approach to abuse of process estoppel, the court found no reason to depart from the conclusion that Plaintiff should be permitted to bring its claim, especially given its independence and changed business focus.
The court found no error of law or principle in the judge’s conclusions and upheld the reasoning that Plaintiff was not precluded from challenging the Patent or SPC.
Holding and Implications
DISMISSED
The court dismissed the appeal, holding that Plaintiff is not estopped by reason of privity of interest from challenging the validity of the Patent and SPC despite its prior corporate association with Company C. The decision confirms that privity of interest requires a concrete and continuing legal interest and sufficient identification with the party to the earlier proceedings, which was not established here.
The direct effect is that Plaintiff may proceed with its revocation action. No new precedent was established beyond reaffirming the narrow scope of privity of interest and the importance of procedural fairness in estoppel cases involving corporate groups.
Alert